These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 34075567)

  • 1. Adjunctive Perampanel in Older Patients With Epilepsy: A Multicenter Study of Clinical Practice.
    Lattanzi S; Cagnetti C; Foschi N; Ciuffini R; Osanni E; Chiesa V; Dainese F; Dono F; Canevini MP; Evangelista G; Paladin F; Bartolini E; Ranzato F; Nilo A; Pauletto G; Marino D; Rosati E; Bonanni P; Marrelli A
    Drugs Aging; 2021 Jul; 38(7):603-610. PubMed ID: 34075567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study.
    Pascarella A; Manzo L; Gasparini S; Marsico O; Abelardo D; Torino C; Cianci V; Iudice A; Bisulli F; Bonanni P; Caggia E; D'Aniello A; Di Bonaventura C; DiFrancesco JC; Domina E; Dono F; Gambardella A; Fortunato F; Marini C; Marrelli A; Matricardi S; Morano A; Paladin F; Renna R; Piccioli M; Striano P; Ascoli M; La Neve A; Le Piane E; Orsini A; Di Gennaro G; Aguglia U; Ferlazzo E;
    J Neurol Sci; 2024 Jul; 462():123106. PubMed ID: 38925069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of adjunctive Perampanel in a prospective, real-world, Phase IV study in Indian patients aged ≥12 years for Treatment of focal-onset Epilepsy: Study 508.
    Ravat S; Rohatgi A; Kulkarni R; Jabeen SA; Patil B; Dash A; Malhotra M
    Epilepsia Open; 2024 Jun; 9(3):940-950. PubMed ID: 38124551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study.
    Villanueva V; Garcés M; López-González FJ; Rodriguez-Osorio X; Toledo M; Salas-Puig J; González-Cuevas M; Campos D; Serratosa JM; González-Giráldez B; Mauri JA; Camacho JL; Suller A; Carreño M; Gómez JB; Montoya J; Rodríguez-Uranga J; Saiz-Diaz R; González-de la Aleja J; Castillo A; López-Trigo J; Poza JJ; Flores J; Querol R; Ojeda J; Giner P; Molins A; Esteve P; Baiges JJ
    Epilepsy Res; 2016 Oct; 126():201-10. PubMed ID: 27521586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST).
    Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Cerulli Irelli E; Chiesa V; Dainese F; De Maria G; Didato G; Falcicchio G; Fanella M; Ferlazzo E; Gangitano M; Giorgi FS; La Neve A; Mecarelli O; Montalenti E; Morano A; Piazza F; Pulitano P; Quarato PP; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
    Drugs Aging; 2022 Apr; 39(4):297-304. PubMed ID: 35344198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PERPRISE: A prospective non-interventional study of PERampanel as only adjunctive treatment in patients with PRImary or SEcondarily generalized tonic-clonic seizures: First interim analysis.
    Steinhoff BJ; Goldmann T; Kockelmann E; Winter Y;
    Epilepsia Open; 2024 Jun; 9(3):926-939. PubMed ID: 38017663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST).
    Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Chiesa V; Dainese F; De Maria G; Didato G; Falcicchio G; Fanella M; Ferlazzo E; Fisco G; Gangitano M; Giallonardo AT; Giorgi FS; La Neve A; Mecarelli O; Montalenti E; Piazza F; Pulitano P; Quarato PP; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
    CNS Drugs; 2021 Dec; 35(12):1289-1301. PubMed ID: 34476770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year clinical experience of perampanel in Spain: a multicentre study of efficacy and tolerability.
    Garamendi-Ruiz I; García-García ME; Bertol-Alegre V; Mauri-Llerda JÁ; García-Morales I; Garayoa-Irigoyen V; Agúndez-Sarasola M; De Toledo-Heras M; García-Morales V; García-Gomara MJ; Arcos-Sánchez C; Gago-Veiga A; Escalza-Cortina I; Rueda-Mena E; Muñoz-Fargas E; Santos-Lasaosa S; Oliván-Usieto JA; Julián LD; Gómez-Esteban JC; Marinas-Alejo A
    Epileptic Disord; 2016 Jun; 18(2):173-80. PubMed ID: 27238234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study.
    D'Souza W; Alsaadi T; Montoya J; Carreño M; Di Bonaventura C; Mohanraj R; Yamamoto T; McMurray R; Shastri O; Villanueva V;
    Seizure; 2022 Aug; 100():56-66. PubMed ID: 35777333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of perampanel as the first add-on therapy for children with epilepsy: A real-world multicenter prospective observational study.
    Mai J; Li H; He Y; Huang T; Lin C; Lan S; Xiao X; He S; Lu X; Chen L; Li B; Luo X; Wang H; Liao J; Cao D
    Seizure; 2024 Apr; 117():44-49. PubMed ID: 38308908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre.
    Morano A; Fattouch J; Albini M; Casciato S; Fanella M; Basili LM; Viganò A; Manfredi M; Giallonardo AT; Di Bonaventura C
    J Neurol Sci; 2018 Jul; 390():67-74. PubMed ID: 29801910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures.
    Gidal BE; Ferry J; Majid O; Hussein Z
    Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cenobamate KORK study-A prospective monocenter observational study investigating cenobamate as an adjunctive therapy in refractory epilepsy, with comparisons to historical cohorts treated with add-on lacosamide, perampanel, and brivaracetam.
    Steinhoff BJ; Georgiou D; Intravooth T
    Epilepsia Open; 2024 Aug; 9(4):1502-1514. PubMed ID: 38861254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice.
    Alonso-Singer P; Aguilar-Amat Prior MJ; Oliva-Navarro J; Massot-Tarrús A; Giráldez BG; Bermejo P; DeToledo-Heras M; Aledo-Serrano Á; Martínez-Cayuelas E; Tirado-Requero P; Velázquez-Fragua R; López-Sobrino G; Ojeda J
    Epilepsy Behav; 2022 Sep; 134():108836. PubMed ID: 35870432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perampanel for the treatment of people with idiopathic generalized epilepsy in clinical practice.
    Trinka E; Alsaadi T; Goji H; Maehara T; Takahashi S; Jacobs J; Renna R; Gil-López FJ; McMurray R; Sáinz-Fuertes R; Villanueva V
    Epilepsia; 2023 Aug; 64(8):2094-2107. PubMed ID: 37114853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term tolerability, safety and efficacy of adjunctive perampanel in the open-label, dose-ascending Study 231 and extension Study 233 in Japanese patients with epilepsy.
    Usui N; Akamatsu N; Nakasato N; Ohnishi A; Kaneko S; Hiramatsu H; Saeki K; Miyagishi H; Inoue Y
    Seizure; 2018 Nov; 62():26-32. PubMed ID: 30267941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of mono- and add-on perampanel in pediatric patients with epilepsy: Experience from a single-center retrospective study.
    Li Y; Guo HL; Hu YH; Wang J; Zhang YY; Huang J; Xu J; Chen J; Lu XP; Chen F
    Epilepsia Open; 2024 Feb; 9(1):268-277. PubMed ID: 37943144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electro-clinical analysis of epilepsy patients with generalized seizures on adjunctive perampanel treatment.
    Montoya Gutiérrez FJ; Díaz Román M; Cerveró Albert D
    Epilepsy Res; 2020 Sep; 165():106378. PubMed ID: 32622260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary Asian experience of using perampanel in clinical practice.
    Chiang HI; Lim SN; Hsieh HY; Cheng MY; Chang CW; Johnny Tseng WE; Li HT; Lin CY; Wu T
    Biomed J; 2017 Dec; 40(6):347-354. PubMed ID: 29433838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The real-world effectiveness and safety of perampanel in Europe: A scoping review.
    Estévez-María JC; Garamendi-Ruiz I
    Epilepsy Behav; 2022 Sep; 134():108777. PubMed ID: 35816832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.